Search Results - person:"Åkerborg, Örjan"

Cost-effectiveness analysis of dronedarone versus other anti-arrhythmic drugs for the treatment of atrial fibrillation : results for Canada, Italy, Sweden and Switzerland

Nilsson, Jonas; Åkerborg, Örjan; Bégo-Le Bagousse, … - In: The European journal of health economics : HEPAC ; … 14 (2013) 3, pp. 481-493

Persistent link: https://www.econbiz.de/10009757486

Cost-effectiveness analysis of dronedarone versus other anti-arrhythmic drugs for the treatment of atrial fibrillation—results for Canada, Italy, Sweden and Switzerland

Nilsson, Jonas; Åkerborg, Örjan; Bagousse, Gaëlle … - In: The European Journal of Health Economics 14 (2013) 3, pp. 481-493

The ATHENA clinical trial enrolled 4,628 patients in 37 countries and evaluated the efficacy of dronedarone 400 mg twice daily versus placebo for the prevention of cardiovascular hospitalisation or death from any cause in patients with paroxysmal or persistent atrial fibrillation or atrial...

Persistent link: https://www.econbiz.de/10010993826